Firefly Neuroscience (AIFF) EBT (2010 - 2026)

Firefly Neuroscience's EBT history runs 16 years deep, the most recent figure standing at -$2.0 million for Q1 2026.

• In Q1 2026, EBT rose 84.5% year-over-year to -$2.0 million; the TTM figure through Mar 2026 stood at -$9.0 million (up 54.34% YoY), while the FY2025 annual figure was -$19.9 million, down 90.07% from the prior year.
• EBT was -$2.0 million for Q1 2026 at Firefly Neuroscience, up from -$2.5 million in the prior quarter.
• In the past five years, EBT ranged from a high of $456438.0 in Q2 2023 to a low of -$12.9 million in Q1 2025.
• Historically, EBT has averaged -$2.3 million across 5 years, with a median of -$1.4 million in 2022.
• The sharpest annual moves came in 2022 and 2023: EBT tumbled 3851.17% in 2022, then soared 128.19% in 2023.
• A 5-year view of EBT shows it stood at -$1.0 million in 2022, then decreased by 4.32% to -$1.1 million in 2023, then sank by 298.61% to -$4.3 million in 2024, then surged by 42.2% to -$2.5 million in 2025, then gained by 19.16% to -$2.0 million in 2026.
• The last three EBT figures came in at -$2.0 million (Q1 2026), -$2.5 million (Q4 2025), and -$2.6 million (Q3 2025), per Business Quant data.